Royal Bank of Canada’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.4M | Sell |
|
|||||
|
2025
Q2 | $5.46M | Buy |
|
|||||
|
2025
Q1 | $196K | Sell |
|
|||||
|
2024
Q4 | $357K | Sell |
|
|||||
|
2024
Q3 | $639K | Buy |
|
|||||
|
2024
Q2 | $354K | Buy |
|
|||||
|
2024
Q1 | $146K | Sell |
|
|||||
|
2023
Q4 | $834K | Buy |
|
|||||
|
2023
Q3 | $371K | Buy |
|
|||||
|
2023
Q2 | $310K | Buy |
|
|||||
|
2023
Q1 | $209K | Sell |
|
|||||
|
2022
Q4 | $535K | Buy |
|
|||||
|
2022
Q3 | $123K | Sell |
|
|||||
|
2022
Q2 | $394K | Buy |
|
|||||
|
2022
Q1 | $269K | Sell |
|
|||||
|
2021
Q4 | $412K | Buy |
|
|||||
|
2021
Q3 | $205K | Sell |
|
|||||
|
2021
Q2 | $892K | Sell |
|
|||||
|
2021
Q1 | $2.06M | Buy |
|
|||||
|
2020
Q4 | $2M | Buy |
|
|||||
|
2020
Q3 | $57K | Buy |
|
|||||
|
2020
Q2 | $31K | Sell |
|
|||||
|
2020
Q1 | $25K | Sell |
|
|||||
|
2019
Q4 | $93K | Buy |
|
|||||
|
2019
Q3 | $6K | Hold |
|
|||||
|
2019
Q2 | $8K | Sell |
|
|||||
|
2019
Q1 | $9K | Sell |
|
|||||
|
2018
Q4 | $16K | Sell |
|
|||||
|
2018
Q3 | $34K | Buy |
|
|||||
|
2018
Q2 | $1K | Sell |
|
|||||
|
2018
Q1 | $1K | Sell |
|
|||||
|
2017
Q4 | $16K | Buy |
|